The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes

Diabetes - United States
doi 10.2337/diabetes.51.9.2826
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Aminoguanidine Treatment Inhibits the Development of Experimental Diabetic Retinopathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Correction: Aminoguanidine Teatment Inhibits the Development of Experimental Diabetic Retinopathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

A Novel Inhibitor of Advanced Glycation End-Product Formation Inhibits Mesenteric Vascular Hypertrophy in Experimental Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Aminoguanidine Inhibits the Development of Accelerated Diabetic Retinopathy in the Spontaneous Hypertensive Rat

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1994English

Metabolic Interactions of AGE Inhibitor Pyridoxamine and Antioxidant Α-Lipoic Acid Following 22 Weeks of Treatment in Obese Zucker Rats

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2009English

The Retinal Proteome in Experimental Diabetic Retinopathy

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2008English

Erratum To: CX3CR1 Deficiency Accelerates the Development of Retinopathy in a Rodent Model of Type 1 Diabetes

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2017English

Retinopathy at Diagnosis of Diabetes, With Special Reference to Patients Under 40 Years of Age

BMJ
1969English

Higher Levels of Prorenin Predict Development of Diabetic Retinopathy in Patients With Type 2 Diabetes

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy